Literature DB >> 7603326

The induction of aneuploidy by alkylated purines: effects on early and late cell cycle events.

M Simili1, P Pellerano, G Tavosanis, G Arena, S Bonatti, A Abbondandolo.   

Abstract

It has been shown that alkylated bases induce aneuploidy in mammalian cells in culture. The mechanism of action is not clear, however, data with 6-dimethyl amino purine (6DMAP) suggest that this analogue might act by affecting the cytoskeleton and protein kinases involved in cell cycle regulation (cdc2/p34). The aim of this work was to study the effect of O6methylguanine (O6meG), O6ethylguanine (O6etG) and 6DMAP on DNA synthesis induced by growth factors in two cell lines, 3T3 and CHEF/18 fibroblasts, which respond in opposite ways to substances affecting the cytoskeleton, colchicine and cholera toxin: DNA synthesis initiation is stimulated in 3T3 cells and inhibited in CHEF/18 cells by such compounds. Our results indicate that O6meG and O6etG behave like cholera toxin, in as much as they inhibit DNA synthesis induced by epidermal growth factor plus insulin in CHEF/18 cells, and stimulate it in 3T3 cells. 6DMAP behaves differently and inhibits DNA synthesis in both cell lines. The inhibition (or stimulation) was greater when alkylated bases were added before S phase started, suggesting that these compounds might affect early events of the cell cycle. In CHEF/18 cells the three alkylated bases were able to induce aberrant metaphases and ana-telophases with different efficiency (70-100%). The effect was not dependent on the G1-S block and it was reversible even after cell commitment to DNA synthesis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7603326     DOI: 10.1093/mutage/10.2.105

Source DB:  PubMed          Journal:  Mutagenesis        ISSN: 0267-8357            Impact factor:   3.000


  2 in total

1.  Safety, pharmacokinetics and antiviral activity of AT-527, a novel purine nucleotide prodrug, in HCV-infected subjects with and without cirrhosis.

Authors:  Elina Berliba; Maxim Bogus; Frédéric Vanhoutte; Pieter-Jan Berghmans; Steven S Good; Adel Moussa; Keith Pietropaolo; Robert L Murphy; Xiao-Jian Zhou; Jean-Pierre Sommadossi
Journal:  Antimicrob Agents Chemother       Date:  2019-09-30       Impact factor: 5.191

2.  Preclinical evaluation of AT-527, a novel guanosine nucleotide prodrug with potent, pan-genotypic activity against hepatitis C virus.

Authors:  Steven S Good; Adel Moussa; Xiao-Jian Zhou; Keith Pietropaolo; Jean-Pierre Sommadossi
Journal:  PLoS One       Date:  2020-01-08       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.